Docetaxel injection had a market value of roughly $10 million in the 12 months ended March 2021, according to IQVIA. Hikma is offering docetaxel injection in 20mg/mL and 80mg/4mL doses. Docetaxel is ...
Serial multiomic analysis in advanced breast cancer: A novel platform to inform therapeutic decisions. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not ...
Alembic is introducing Docetaxel injection, 20 mg/2 ml (10 mg/ml), 80 mg/8 ml (10 mg/ml) and 160 mg/16 ml (10 mg/ml), which is the generic of Hospira’s Docetaxel injection. Docetaxel injection is a ...
The U.S. Food and Drug Administration (FDA) has approved Teikoku Pharma USA's nonalcohol docetaxel injection for the treatment of head and neck cancer, breast cancer, non-small cell lung cancer, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results